Literature DB >> 637974

Treatment of patients with transposition of great arteries and pulmonary vascular obstructive disease.

J Byrne, D Clarke, J F Taylor, F Macartney, M de Leval, J Stark.   

Abstract

Twenty-two patients with transposition of the great arteries with or without ventricular septal defect and one with double outlet right ventricle, d-malposition, and severe pulmonary vascular obstructive disease were treated surgically. All were cyanosed and had very limited exercise tolerance. Preoperatively, systemic arterial oxygen saturation (SaO2) varied from 45 to 79% (mean 65), haemoglobin was 13 to 23 g/dl (mean 19). Pulmonary arteriolar resistance was 6.4 to 35 units m2 (mean 17). In the patients with a ventricular septal defect the Mustard operation was done without closure of the ventricular septal defect, and in the 3 patients with intact ventricular septum the Mustard operation was combined with creation of a ventricular septal defect. All patients survived the operation and improved. Postoperative SaO2 ranged from 75 to 96% (mean 89) and haemoglobin from 10.6 to 17.8 g/dl (mean 14.0). This improvement was significant (P less than 0.05). Five patients have had a postoperative cardiac catheterisation. The pulmonary arteriolar resistance remains high in all. Postoperative follow-up varies from 4 to 40 months (mean 14 months). So far there have been no late deaths and all patients remain improved.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 637974      PMCID: PMC481985          DOI: 10.1136/hrt.40.3.221

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  11 in total

1.  Proceedings: Mustard operation in patients with pulmonary vascular disease.

Authors:  J Stark; S Saw; M R de Leval; J F Taylor
Journal:  Br Heart J       Date:  1976-03

2.  Operation results for transposition of the great arteries.

Authors:  J Stark
Journal:  Adv Cardiol       Date:  1976

3.  The Mustard operation as a palliative procedure.

Authors:  G G Lindesmith; Q R Stiles; B L Tucker; M E Gallaher; R E Stanton; B W Meyer
Journal:  J Thorac Cardiovasc Surg       Date:  1972-01       Impact factor: 5.209

4.  Pulmonary vascular disease in complete transposition of the great arteries: a study of 200 patients.

Authors:  E A Newfeld; M M Paul; A J Muster; F S Idriss
Journal:  Am J Cardiol       Date:  1974-07       Impact factor: 2.778

5.  Hemodynamics and evaluation for surgery of patients with complete transposition of the great arteries and ventricular septal defect.

Authors:  D D Mair; D G Ritter; P A Ongley; H F Helmholz
Journal:  Am J Cardiol       Date:  1971-12       Impact factor: 2.778

6.  The spectrum of pulmonary vascular disease in transposition of the great arteries.

Authors:  P H Viles; P A Ongley; J L Titus
Journal:  Circulation       Date:  1969-07       Impact factor: 29.690

7.  An assessment of Mustard's operation as a palliative procedure for transposition of the great vessels.

Authors:  G G Lindesmith; R E Stanton; P R Lurie; M Takahashi; B L Tucker; Q R Stiles; B W Meyer
Journal:  Ann Thorac Surg       Date:  1975-05       Impact factor: 4.330

8.  The palliative Mustard operation: rationale and results.

Authors:  D D Mair; D G Ritter; G K Danielson; R B Wallace; D C McGoon
Journal:  Am J Cardiol       Date:  1976-04       Impact factor: 2.778

9.  The palliative Mustard operation for double outlet right ventricle or transposition of the great arteries associated with ventricular septal defect, pulmonary arterial hypertension, and pulmonary vascular obstructive disease. A report of eight patients.

Authors:  W F Bernhard; M Dick; L J Sloss; A R Castaneda; A S Nadas
Journal:  Circulation       Date:  1976-11       Impact factor: 29.690

10.  Mustard operation and creation of ventricular septal defect in two patients with transposition of the great arteries, intact ventricular septum and pulmonary vascular disease.

Authors:  J Stark; M R de Leval; J F Taylor
Journal:  Am J Cardiol       Date:  1976-10       Impact factor: 2.778

View more
  1 in total

1.  Ventilatory function in the Eisenmenger syndrome.

Authors:  C G MacArthur; D Hunter; G J Gibson
Journal:  Thorax       Date:  1979-06       Impact factor: 9.139

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.